Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin

Cochrane corner: vitamin K for improved anticoagulation control in patients receiving warfarin

Detalhes bibliográficos
Principais autores:	Mahtani, K, Nunan, D, Heneghan, C
Formato:	Journal article
Idioma:	English
Publicado em:	BMJ Publishing Group 2015

Registros relacionados

Vitamin K for improved anticoagulation control in patients receiving warfarin
por: Mahtani, K, et al.
Publicado em: (2014)

Cochrane corner: self-monitoring and self-management of oral anticoagulation.
por: Heneghan, C, et al.
Publicado em: (2017)

Optimal loading dose of warfarin for the initiation of oral anticoagulation.
por: Mahtani, K, et al.
Publicado em: (2012)

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
por: Jo-Nan Liao, et al.
Publicado em: (2022-07-01)

Safety and effectiveness of anticoagulation with non-vitamin K antagonist oral anticoagulants and warfarin in patients on tuberculosis treatment
por: Hyun-Jung Lee, et al.
Publicado em: (2023-02-01)

Physical activity interventions and chronic diseases: A matched-pair analysis comparing Cochrane and non-Cochrane Systematic Reviews
por: Hacke, C, et al.
Publicado em: (2017)

Cochrane corner: water for wound cleansing.
por: Henton, J, et al.
Publicado em: (2012)

Cochrane corner: water for wound cleansing.
por: Henton, J, et al.
Publicado em: (2012)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
Publicado em: (2020-02-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: Mu-Mei Hu, et al.
Publicado em: (2017-04-01)

Risk of Osteoporosis in Patients With Atrial Fibrillation Using Non–Vitamin K Antagonist Oral Anticoagulants or Warfarin
por: Huei‐Kai Huang, et al.
Publicado em: (2020-01-01)

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation.
por: Seong Huan Choi, et al.
Publicado em: (2022-01-01)

Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation
por: Seong Huan Choi, et al.
Publicado em: (2022-01-01)

Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
por: Hsin‐Fu Lee, et al.
Publicado em: (2019-03-01)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
por: Heng Cai, et al.
Publicado em: (2020-01-01)

Anticoagulation for Atrial Fibrillation in Cirrhosis of the Liver: Are Low‐Dose Non‐Vitamin K Oral Anticoagulants a Reasonable Alternative to Warfarin?
por: Celine Gallagher, et al.
Publicado em: (2019-03-01)

A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study
por: Andrea L Jorgensen, et al.
Publicado em: (2023-07-01)

Cochrane Corner: Coronavirus (COVID-19): infection control and prevention measures
por: Vanessa Jordan
Publicado em: (2020-01-01)

Comparison of Early Complications of Oral Anticoagulants after Totally Thoracoscopic Ablation: Warfarin versus Non-vitamin K Antagonist Oral Anticoagulants
por: MuHyung Heo, et al.
Publicado em: (2023-03-01)

Comparison of ََQuality of Life and Treatment Satisfaction among Sample of Iraqi Patients Using Anticoagulant Therapy (Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants)
por: Basma Z. Al-Metwali, et al.
Publicado em: (2024-10-01)

Anticoagulation Management in Patients Receiving Warfarin at Private Cardiac Centers in Addis Ababa, Ethiopia
por: Getachew R, et al.
Publicado em: (2023-02-01)

Cochrane Corner: Withdrawal of antihypertensive drugs in older people
por: Filipa Reis, et al.
Publicado em: (2021-05-01)

Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
por: Salih Kilic, et al.
Publicado em: (2018-01-01)

Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia
por: Nuredin Shiferaw Yimer, et al.
Publicado em: (2021-10-01)

Comparison of hospital length of stay in patients treated with non–vitamin K oral anticoagulants or parenteral agents plus warfarin for venous thromboembolism
por: Catherine A Saint, et al.
Publicado em: (2017-07-01)

Patient adherence to warfarin therapy and its impact on anticoagulation control
por: Ahmed Y. Mayet
Publicado em: (2016-01-01)

Cochrane corner: antibiotic prophylaxis for mammalian bites (intervention review).
por: Henton, J, et al.
Publicado em: (2012)

Cochrane corner: antibiotic prophylaxis for mammalian bites (intervention review).
por: Henton, J, et al.
Publicado em: (2012)

Cochrane Corner: colchicina na pericardite aguda e recorrente
por: Daniel Caldeira, et al.
Publicado em: (2015-11-01)

O Cochrane Corner da Revista Portuguesa de Cardiologia
por: António Vaz Carneiro
Publicado em: (2013-11-01)

Vitamina K: metabolismo, fontes e interação com o anticoagulante varfarina Vitamin K: metabolism, sources and interaction with the anticoagulant warfarin
por: Karin Klack, et al.
Publicado em: (2006-12-01)

Anticoagulation Quality of Warfarin and the Role of Physician–Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study
por: Sha Qiu, et al.
Publicado em: (2021-01-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
por: I. Yu. Koroleva, et al.
Publicado em: (2016-11-01)

Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review
por: Tamrat Assefa Tadesse, et al.
Publicado em: (2022-10-01)

Real‐life experience with non‐vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation
por: Saga Itäinen‐Strömberg, et al.
Publicado em: (2020-09-01)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
por: Yuqing Deng, et al.
Publicado em: (2019-07-01)

Device-guided breathing exercises in the control of human blood pressure: systematic review and meta-analysis.
por: Mahtani, K, et al.
Publicado em: (2012)

The Impact on Efficacy and Safety of Patients Receiving Oral Anticoagulant Medication (Warfarin) during the COVID-19 Pandemic
por: Ubonwan Sapoo, et al.
Publicado em: (2024-07-01)

Management of haemorrhage in patients receiving non-vitamin-k oral anticoagulants treatment: Case report
por: Rangelov-Kulezić Jasmina, et al.
Publicado em: (2022-01-01)

Effect of Some Risk Factors on Over-Anticoagulation Disorders and Bleeding in Patients Receiving Anticoagulant Therapy with Overdosage of Vitamin K Antagonist
por: Dung Chu S, et al.
Publicado em: (2023-10-01)